Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Drugs - Real World Outcomes
|
October 18, 2016
Claims Data Analysis of Tumor Necrosis Factor Inhibitor Treatment Dosing Among Patients with Rheumatoid Arthritis: A Systematic Review of Methods
Gundula Krack, Henning Zeidler, Jan Zeidler
European Journal of Ageing
|
December 12, 2022
A systematic review to identify the use of stated preference research in the field of older adult care
Lea de Jong, Jan Zeidler, Kathrin Damm
The International Journal of Eating Disorders
|
March 10, 2025
Health Economic Evaluation of Cognitive-Behavioral Therapy for Adolescents With Binge-Eating Disorder in Germany
Nicolas Pardey, Ricarda Schmidt, Jan Zeidler, et al.
Applied Health Economics and Health Policy
|
August 27, 2013
Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany
Jan Zeidler, Jörg Mahlich, Wolfgang Greiner, et al.
Health Economics Review
|
July 26, 2012
The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective
Jan Zeidler, Lara Slawik, Jochen Fleischmann, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
January 23, 2026
Socioeconomic deprivation and survival among patients with non-small cell lung cancer (NSCLC): Investigation using population-based Clinical Cancer Registry data of Lower Saxony Germany) and discussion of worldwide evidence
Adrian Rohde, Mike Klora, Tonia Brand, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 24, 2016
Access, use, and challenges of claims data analyses in Germany
Sarah Neubauer, Kristine Kreis, Mike Klora, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 18, 2019
[Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data]
Sarah Neubauer, Henning Zeidler, Roland Linder, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
July 14, 2021
[Healthcare expenditure and the impact of age: a detailed analysis for survivors and decedents]
Jona T Stahmeyer, Sascha Hamp, Jan Zeidler, et al.
Health Economics Review
|
October 2, 2012
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Jan Zeidler, Thomas Mittendorf, Rüdiger Müller, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Drugs - Real World Outcomes
|
October 18, 2016
Claims Data Analysis of Tumor Necrosis Factor Inhibitor Treatment Dosing Among Patients with Rheumatoid Arthritis: A Systematic Review of Methods
Gundula Krack, Henning Zeidler, Jan Zeidler
European Journal of Ageing
|
December 12, 2022
A systematic review to identify the use of stated preference research in the field of older adult care
Lea de Jong, Jan Zeidler, Kathrin Damm
The International Journal of Eating Disorders
|
March 10, 2025
Health Economic Evaluation of Cognitive-Behavioral Therapy for Adolescents With Binge-Eating Disorder in Germany
Nicolas Pardey, Ricarda Schmidt, Jan Zeidler, et al.
Applied Health Economics and Health Policy
|
August 27, 2013
Cost effectiveness of paliperidone palmitate for the treatment of schizophrenia in Germany
Jan Zeidler, Jörg Mahlich, Wolfgang Greiner, et al.
Health Economics Review
|
July 26, 2012
The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective
Jan Zeidler, Lara Slawik, Jochen Fleischmann, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
January 23, 2026
Socioeconomic deprivation and survival among patients with non-small cell lung cancer (NSCLC): Investigation using population-based Clinical Cancer Registry data of Lower Saxony Germany) and discussion of worldwide evidence
Adrian Rohde, Mike Klora, Tonia Brand, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 24, 2016
Access, use, and challenges of claims data analyses in Germany
Sarah Neubauer, Kristine Kreis, Mike Klora, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 18, 2019
[Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data]
Sarah Neubauer, Henning Zeidler, Roland Linder, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
July 14, 2021
[Healthcare expenditure and the impact of age: a detailed analysis for survivors and decedents]
Jona T Stahmeyer, Sascha Hamp, Jan Zeidler, et al.
Health Economics Review
|
October 2, 2012
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Jan Zeidler, Thomas Mittendorf, Rüdiger Müller, et al.
Page
of 8